AmplifAI, a Texas-based AI-powered contact center platform, has secured $33.7M in Series B funding, led by CVS Health Ventures, with contributions from LiveOak Ventures and Dallas Venture Partners. This investment aims to enhance human and AI agent integration, optimizing customer experience amidst rising cost pressures in contact centers. AmplifAI’s innovative platform allows human agents to handle complex queries while AI manages routine tasks, driving efficiency and improving service quality. Notably, it leverages generative AI to analyze multi-channel data, revealing customer insights and enabling real-time coaching for agents. Companies using AmplifAI, including those in healthcare and retail, have reported over 100% increases in sales conversions and 20% improvements in resolution rates. Recognized by Gartner as a “Cool Vendor,” AmplifAI continues to transform customer interactions, helping organizations achieve measurable business results. For more information, visit AmplifAI’s website.
Source link
